409 related articles for article (PubMed ID: 18502820)
1. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
[TBL] [Abstract][Full Text] [Related]
2. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women.
Mencej S; Prezelj J; Kocijancic A; Ostanek B; Marc J
Maturitas; 2006 Oct; 55(3):219-26. PubMed ID: 16730419
[TBL] [Abstract][Full Text] [Related]
3. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J
J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
Firat SC; Cetin Z; Samanci N; Aydin F; Balci N; Gungor F; Firat MZ; Luleci G; Karauzum SB
Maturitas; 2009 Aug; 63(4):352-6. PubMed ID: 19520527
[TBL] [Abstract][Full Text] [Related]
5. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
6. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
Mencej-Bedrač S; Preželj J; Marc J
Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
[TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
[TBL] [Abstract][Full Text] [Related]
8. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
[TBL] [Abstract][Full Text] [Related]
9. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
[TBL] [Abstract][Full Text] [Related]
10. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
[TBL] [Abstract][Full Text] [Related]
11. -643C > T RANKL gene polymorphism is associated with osteoporosis in Tunisian postmenopausal women.
Sassi R; Sahli H; Cheour E; Sellami S; El Gaaied ABA
Climacteric; 2017 Aug; 20(4):374-378. PubMed ID: 28453307
[TBL] [Abstract][Full Text] [Related]
12. Association of a RUNX2 promoter polymorphism with bone mineral density in postmenopausal Korean women.
Lee HJ; Koh JM; Hwang JY; Choi KY; Lee SH; Park EK; Kim TH; Han BG; Kim GS; Kim SY; Lee JY
Calcif Tissue Int; 2009 Jun; 84(6):439-45. PubMed ID: 19424741
[TBL] [Abstract][Full Text] [Related]
13. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck bmd in Spanish postmenopausal women.
Bustamante M; Nogués X; Agueda L; Jurado S; Wesselius A; Cáceres E; Carreras R; Ciria M; Mellibovsky L; Balcells S; Díez-Pérez A; Grinberg D
Calcif Tissue Int; 2007 Oct; 81(4):327-32. PubMed ID: 17878995
[TBL] [Abstract][Full Text] [Related]
14. Raloxifene pharmacodynamics is influenced by genetic variants in the RANKL/RANK/OPG system and in the Wnt signaling pathway.
Mencej-Bedrač S; Zupan J; Mlakar SJ; Zavratnik A; Preželj J; Marc J
Drug Metabol Drug Interact; 2014; 29(2):111-4. PubMed ID: 24615483
[TBL] [Abstract][Full Text] [Related]
15. HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia.
Hwang JY; Lee SH; Kim GS; Koh JM; Go MJ; Kim YJ; Kim HC; Kim TH; Hong JM; Park EK; Lee JY; Kim SY
Bone; 2009 Dec; 45(6):1098-103. PubMed ID: 19651257
[TBL] [Abstract][Full Text] [Related]
16. Large-scale population-based study shows no association between common polymorphisms of the TGFB1 gene and BMD in women.
McGuigan FE; Macdonald HM; Bassiti A; Farmer R; Bear S; Stewart A; Black A; Fraser WD; Welsh F; Reid DM; Ralston SH
J Bone Miner Res; 2007 Feb; 22(2):195-202. PubMed ID: 17059371
[TBL] [Abstract][Full Text] [Related]
17. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women.
Rojano-Mejía D; Coral-Vázquez RM; Espinosa LC; Romero-Hidalgo S; López-Medina G; García Mdel C; Coronel A; Ibarra R; Canto P
Maturitas; 2012 Jan; 71(1):49-54. PubMed ID: 22079369
[TBL] [Abstract][Full Text] [Related]
18. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
[TBL] [Abstract][Full Text] [Related]
19. Association between SNP and haplotypes in PPARGC1 and adiponectin genes and bone mineral density in Chinese nuclear families.
Zhang ZL; He JW; Qin YJ; Hu YQ; Li M; Liu YJ; Zhang H; Hu WW
Acta Pharmacol Sin; 2007 Feb; 28(2):287-95. PubMed ID: 17241533
[TBL] [Abstract][Full Text] [Related]
20. Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men.
Yamada Y; Ando F; Niino N; Shimokata H
Mol Genet Metab; 2003 Nov; 80(3):344-9. PubMed ID: 14680982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
